University of Surrey

Test tubes in the lab Research in the ATI Dance Research

EN2: a novel prostate cancer biomarker.

McGrath, SE, Michael, A, Morgan, R and Pandha, H (2013) EN2: a novel prostate cancer biomarker. Biomark Med, 7 (6). pp. 893-901.

Full text not available from this repository.


Extensive efforts to identify a clinically useful biomarker for the diagnosis of prostate cancer have resulted in important insights into the biology of the disease, but no new test has been approved by regulatory authorities. The unmet need has also shifted to identifying biomarkers that not only diagnose prostate cancer but also indicate whether the patient has 'significant' disease. EN2 is a homeobox-containing transcription factor secreted specifically by prostate cancers into urine, where it can be detected by a simple ELISA assay. A number of studies have demonstrated the enormous potential of EN2 to address this unmet need and provide the urologist with a simple, cheap and efficient prostate cancer biomarker.

Item Type: Article
Divisions : Surrey research (other units)
Authors :
McGrath, SE
Date : December 2013
DOI : 10.2217/bmm.13.115
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:03
Last Modified : 24 Jan 2020 18:23

Actions (login required)

View Item View Item


Downloads per month over past year

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800